| Literature DB >> 27058929 |
Astrid Breitbart1, Charles E Murry2.
Abstract
There is still no curative treatment for Duchenne muscular dystrophy (DMD). In this issue of Cell Stem Cell, Young et al. (2016) demonstrate a genome editing approach applicable to 60% of DMD patients with CRISPR/Cas9 using one pair of guide RNAs.Entities:
Mesh：
Substances：
Year: 2016 PMID： 27058929 DOI： 10.1016/j.stem.2016.03.004
Source DB: PubMed Journal: Cell Stem Cell ISSN： 1875-9777 Impact factor: 24.633